IBD disease-modifying therapies: insights from emerging therapeutics
Author:
Funder
European Regional Development Fund
Horizon 2020
Science Foundation Ireland
Publisher
Elsevier BV
Subject
Molecular Biology,Molecular Medicine
Reference112 articles.
1. The intestinal epithelial barrier: a therapeutic target?;Odenwald;Nat. Rev. Gastroenterol. Hepatol.,2017
2. Intestinal permeability – a new target for disease prevention and therapy;Bischoff;BMC Gastroenterol.,2014
3. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy;Merga;Dig. Dis.,2014
4. Tight junction in the intestinal epithelium: its association with diseases and regulation by phytochemicals;Lee;J. Immunol. Res.,2018
5. Mechanisms regulating intestinal barrier integrity and its pathological implications;Chelakkot;Exp. Mol. Med.,2018
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Signaling Pathways and Molecular Process of Natural Polyphenols in the Amelioration of Inflammatory Bowel Disease: A Privileged Scaffold in New Drug Discovery;Current Drug Research Reviews;2024-03
2. Colon delivery of resveratrol for the treatment of inflammatory bowel disease;Journal of Drug Delivery Science and Technology;2024-02
3. Therapeutic effect of total flavonoids of Sargentodoxa cuneata on ulcerative colitis in mice by correcting gut dysbiosis;Arabian Journal of Chemistry;2024-02
4. The NF-κB signaling system in the immunopathogenesis of inflammatory bowel disease;Science Signaling;2024-01-09
5. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review;Biomaterials Science;2024
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3